Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 19Breast Neoplasms 18Leukemia, Myeloid, Acute 9Ovarian Neoplasms 6Lymphoma 6Hematologic Neoplasms 6Glioblastoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Lung Neoplasms 5Stomach Neoplasms 4Leukemia 4Fatigue 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Myelodysplastic Syndromes 3Motor Activity 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Vaginal Neoplasms 2Sarcoma 2Rectal Neoplasms 2Peritoneal Neoplasms 2Pain 2

Interventions

Drug Therapy 2tremelimumab 1durvalumab 1Watchful Waiting 1Radiotherapy 1Palliative Care 1Magnetic Resonance Spectroscopy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Muscle-invasive Bladder Cancer × Palliative Care × Clear all
NCT06686381 2025-02-05

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

American University of Beirut Medical Center

Phase 2 Not yet recruiting
80 enrolled
Genitourinary

Muscle-invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡